CDNA
CareDx Inc
56.50$
+4.0%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +8.1% | +23.6% | +3.1% | +44.4% | +18.9% | +58.4% | +66.0% | +51.3% | +54.2% | +8.6% | -12.9% | +19.1% | +13.8% | |
| – | +14.5% | -5.9% | +20.3% | +105.6% | +1.2% | +54.4% | +37.8% | +38.9% | +54.3% | +15.2% | -9.1% | +7.5% | +12.4% | |
| – | +4.0% | +44.1% | -4.8% | +9.2% | +38.2% | +61.7% | +87.3% | +58.2% | +54.2% | +5.3% | -14.9% | +25.7% | +14.5% | |
| – | -33.2% | +21.1% | +142.7% | +32.7% | +0.0% | +17.2% | +111.6% | +59.4% | +56.4% | +18.1% | -9.4% | -11.6% | -1.3% | |
| – | +2.4% | +75.4% | +45.2% | +69.2% | -8.7% | +16.1% | +66.4% | +33.6% | +53.6% | +33.9% | +17.4% | +5.0% | -13.1% | |
| – | -6.6% | +35.1% | +59.6% | +47.9% | -0.4% | +31.8% | +82.6% | +42.8% | +50.9% | +25.4% | +33.1% | -52.0% | +53.6% | |
| – | – | – | -1,054.6% | – | – | – | – | – | – | – | – | – | -161.5% | |
| – | -20.5% | -1.5% | -25.0% | +17.2% | +215.2% | -36.9% | +0.0% | -92.7% | +3,453.1% | -60.9% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -139.9% | |
| – | -20.5% | -169.8% | – | -341.5% | – | – | – | – | – | – | -62.8% | +119.9% | -12.6% | |
| – | – | – | -1,855.1% | – | – | – | – | – | – | – | – | – | -140.6% | |
| – | – | – | -2,429.6% | – | – | – | – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.